ArticleCartilage2017
Return to Sports After Bone Marrow-Derived Cell Transplantation for Osteochondral Lesions of the Talus.
Article in Cartilage, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04883892 (BMAC vs HA in Infiltrative Therapy for Osteoarthritis of the Ankle), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
BMAC vs HA in Infiltrative Therapy for Osteoarthritis of the Ankle: Randomized Controlled Clinical Trial
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Pooled it
- Osteochondral Lesions of the Talus: A Review on Talus Osteochondral Injuries, Including Osteochondritis Dissecans.Cartilage · 2021Review
- Return to Sports After Surgical Treatment of Osteochondral Defects of the Talus: A Systematic Review of 2347 Cases.Orthopaedic journal of sports medicine · 2019Review
- Comment on "No superior treatment for primary osteochondral defects of the talus. Dahmen J, et al. KSSTA 2017 Jun 27 PMID:28656457".Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2017Article
- Reply to the letter to the editor: comment on "No superior treatment for primary osteochondral defects of the talus".Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2017Article
- Scaffolds based therapy for osteochondral lesions of the talus: A systematic review.World journal of orthopedics · 2017Article
- Osteochondral lesions of the talus in the athlete: up to date review.Current reviews in musculoskeletal medicine · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveArthroscopic "one-step" technique based on bone marrow-derived cell transplantation (BMDCT) have achieved good results in repairing osteochondral lesions of the talus (OLT), overcoming important drawbacks of older techniques. It may be particularly adequate for the treatment of athletes in order to permit a safe and stable return to sports. The aim of this study was to report the results at 48 months of a series of athletes and the factors influencing the return to sports.
designCase series. A total of 140 athletes underwent a "one-step" BMDCT repair of OLT. All the patients had the cells harvested from the iliac crest, condensed and loaded on a scaffold, and then implanted. Patients were evaluated clinically by the American Orthopaedic Foot and Ankle Society (AOFAS) scores and Halasi score.
resultsAOFAS score improved from 58.7 ± 13.5 preoperatively to 90.6 ± 8.6 (
conclusions"One-step" BMDCT repair of OLT had good clinical results that was durable over time in athletes, permitting a return to sports at preinjury level in the majority of patients. The preoperative presence of impingement and articular degeneration were the main negative prognostic factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.